ID: ALA4174822

Max Phase: Preclinical

Molecular Formula: C39H65N5O9

Molecular Weight: 747.98

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC)OC)N(C)C(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N(C)C

Standard InChI:  InChI=1S/C39H65N5O9/c1-12-25(4)34(43(8)38(49)29(23-45)41-37(48)33(24(2)3)42(6)7)31(51-9)22-32(46)44-20-16-19-30(44)35(52-10)26(5)36(47)40-28(39(50)53-11)21-27-17-14-13-15-18-27/h13-15,17-18,24-26,28-31,33-35,45H,12,16,19-23H2,1-11H3,(H,40,47)(H,41,48)/t25-,26+,28-,29-,30-,31+,33-,34-,35+/m0/s1

Standard InChI Key:  UNXUCSSRFQYTER-ZMRJGPQJSA-N

Associated Targets(Human)

HCC1954 381 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-3 62116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 747.98Molecular Weight (Monoisotopic): 747.4782AlogP: 1.87#Rotatable Bonds: 21
Polar Surface Area: 167.05Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.97CX Basic pKa: 8.03CX LogP: 2.30CX LogD: 1.58
Aromatic Rings: 1Heavy Atoms: 53QED Weighted: 0.16Np Likeness Score: 0.65

References

1. Dugal-Tessier J, Barnscher SD, Kanai A, Mendelsohn BA..  (2017)  Synthesis and Evaluation of Dolastatin 10 Analogues Containing Heteroatoms on the Amino Acid Side Chains.,  80  (9): [PMID:28885014] [10.1021/acs.jnatprod.7b00359]

Source